Suzuki Y - Search Results

1

A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.

Myette JR, Kano T, Suzuki H, Sloan SE, Szretter KJ, Ramakrishnan B, Adari H, Deotale KD, Engler F, Shriver Z, Wollacott AM, Suzuki Y, Pereira BJG. Myette JR, et al. Among authors: suzuki h, suzuki y. Kidney Int. 2019 Jul;96(1):104-116. doi: 10.1016/j.kint.2019.01.031. Epub 2019 Mar 16. Kidney Int. 2019. PMID: 31027890 Free article.

2

Basic research in progressive glomerulopathies: the role of fibrosing factors in IgA nephropathy and diabetic nephropathy.

Tomino Y, Tsuge T, Suzuki Y, Gu L, Tanimoto M, Gohda T, Horikoshi S. Tomino Y, et al. Among authors: suzuki y. Kidney Int Suppl. 2005 Apr;(94):S92-5. doi: 10.1111/j.1523-1755.2005.09422.x. Kidney Int Suppl. 2005. PMID: 15752250 Free article. Review. No abstract available.

3

Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23.

Suzuki H, Suzuki Y, Yamanaka T, Hirose S, Nishimura H, Toei J, Horikoshi S, Tomino Y. Suzuki H, et al. Among authors: suzuki y. J Am Soc Nephrol. 2005 May;16(5):1289-99. doi: 10.1681/ASN.2004030219. Epub 2005 Mar 16. J Am Soc Nephrol. 2005. PMID: 15772254

4

The mucosa-bone-marrow axis in IgA nephropathy.

Suzuki Y, Tomino Y. Suzuki Y, et al. Contrib Nephrol. 2007;157:70-9. doi: 10.1159/000102307. Contrib Nephrol. 2007. PMID: 17495440 Review.

5

Roles of bone marrow, mucosa and lymphoid tissues in pathogenesis of murine IgA nephropathy.

Aizawa M, Suzuki Y, Suzuki H, Pang H, Kihara M, Yamaji K, Horikoshi S, Tomino Y. Aizawa M, et al. Among authors: suzuki h, suzuki y. Contrib Nephrol. 2007;157:164-8. doi: 10.1159/000102462. Contrib Nephrol. 2007. PMID: 17495457

6

Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: insights from animal models.

Suzuki Y, Tomino Y. Suzuki Y, et al. Semin Nephrol. 2008 Jan;28(1):66-77. doi: 10.1016/j.semnephrol.2007.10.008. Semin Nephrol. 2008. PMID: 18222348

7

[Pathogenesis of IgA nephropathy: current understanding of mucosa-bone marrow axis in IgA nephropathy].

Suzuki Y, Suzuki H, Tomino Y. Suzuki Y, et al. Among authors: suzuki h. Nihon Jinzo Gakkai Shi. 2008;50(4):456-60. Nihon Jinzo Gakkai Shi. 2008. PMID: 18546874 Review. Japanese. No abstract available.

8

Toll-like receptor 9 affects severity of IgA nephropathy.

Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T, Kanou T, Tsukaguchi H, Novak J, Horikoshi S, Tomino Y. Suzuki H, et al. Among authors: suzuki y. J Am Soc Nephrol. 2008 Dec;19(12):2384-95. doi: 10.1681/ASN.2007121311. Epub 2008 Sep 5. J Am Soc Nephrol. 2008. PMID: 18776126 Free PMC article.

9

Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.

Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J. Suzuki H, et al. Among authors: suzuki y. J Clin Invest. 2009 Jun;119(6):1668-77. doi: 10.1172/JCI38468. Epub 2009 May 26. J Clin Invest. 2009. PMID: 19478457 Free PMC article.

10

Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy.

Zuo N, Suzuki Y, Sugaya T, Osaki K, Kanaguchi Y, Wang L, Tomino Y. Zuo N, et al. Among authors: suzuki y. Nephrol Dial Transplant. 2011 Jul;26(7):2127-37. doi: 10.1093/ndt/gfq687. Epub 2010 Nov 25. Nephrol Dial Transplant. 2011. PMID: 21109611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,822 results

Search Page

Filters